The resulting opportunities to expand beyond traditional products and markets will enable pharmaceutical companies to evolve into companies that offer a range of health-care solutions. These will include not only prescription medicines, but also diagnostics, branded generics, and technologies that support personalized medicine, as well as so-called “neutraceuticals” and other “wellness options.”
随之产生的机遇将是超越传统产品和市场，使得制药公司发展成为能够提供一系列保健方案的公司。这些方案包括处方药、诊断法、品牌药品及开发个性化药品所需的技术，以及所谓的“保健食品”和其它“健康方案”